Myofibroblast-mediated mechanisms of pathological remodelling of the heart
暂无分享,去创建一个
Ivan C. Gerling | K. Weber | Yao Sun | R. Ahokas | Karl T. Weber | Yao Sun | S. Bhattacharya | Syamal K. Bhattacharya | Robert A. Ahokas | I. Gerling | S. Bhattacharya
[1] S. Dedhar,et al. SPARC Regulates Extracellular Matrix Organization through Its Modulation of Integrin-linked Kinase Activity* , 2005, Journal of Biological Chemistry.
[2] Arantxa González,et al. Clinical aspects of hypertensive myocardial fibrosis , 2001, Current opinion in cardiology.
[3] R. Touyz. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II , 2005, Experimental physiology.
[4] K. Weber,et al. Aldosteronism: an immunostimulatory state precedes proinflammatory/fibrogenic cardiac phenotype. , 2003, American journal of physiology. Heart and circulatory physiology.
[5] S. Nattel,et al. Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. , 2011, Cardiovascular research.
[6] G. Gabbiani,et al. Myofibroblast-Mediated Adventitial Remodeling: An Underestimated Player in Arterial Pathology , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[7] S. Robbins,et al. Pathologic basis of disease , 1974 .
[8] D. Harrison,et al. Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. , 2003, Journal of the renin-angiotensin-aldosterone system : JRAAS.
[9] Y. Sun,et al. Renin expression at sites of repair in the infarcted rat heart. , 2001, Journal of molecular and cellular cardiology.
[10] Arantxa González,et al. Losartan-Dependent Regression of Myocardial Fibrosis Is Associated With Reduction of Left Ventricular Chamber Stiffness in Hypertensive Patients , 2002, Circulation.
[11] G. Laurent,et al. Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. , 1987, The American journal of physiology.
[12] N. de Leeuw,et al. Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy , 2001, Transplant international : official journal of the European Society for Organ Transplantation.
[13] K. Weber,et al. Angiotensin-converting enzyme and wound healing in diverse tissues of the rat. , 1996, The Journal of laboratory and clinical medicine.
[14] M. Eghbali,et al. Expression of fibrillar types I and III and basement membrane collagen type IV genes in myocardium of tight skin mouse. , 1990, Cardiovascular research.
[15] P. J. van der Spek,et al. Impaired Vascular Contractility and Aortic Wall Degeneration in Fibulin-4 Deficient Mice: Effect of Angiotensin II Type 1 (AT1) Receptor Blockade , 2011, PloS one.
[16] K. Weber,et al. Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. , 1994, Cardiovascular research.
[17] E. Sonnenblick,et al. Profound structural alterations of the extracellular collagen matrix in postischemic dysfunctional ("stunned") but viable myocardium. , 1987, Journal of the American College of Cardiology.
[18] B. Lorell. Diastolic dysfunction in pressure-overload hypertrophy and its modification by angiotensin II: current concepts. , 1992, Basic research in cardiology.
[19] W. Roberts,et al. Comparison of clinical and morphologic cardiac findings in patients having cardiac transplantation for ischemic cardiomyopathy, idiopathic dilated cardiomyopathy, and dilated hypertrophic cardiomyopathy. , 1998, The American journal of cardiology.
[20] P. Rabinovitch,et al. Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy. , 2011, Journal of the American College of Cardiology.
[21] K. Weber,et al. Mitochondria play a central role in nonischemic cardiomyocyte necrosis: common to acute and chronic stressor states , 2012, Pflügers Archiv - European Journal of Physiology.
[22] L. Reimer,et al. Scanning Electron Microscopy , 1984 .
[23] O. Hess,et al. Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. , 1989, Circulation.
[24] G. Cooper. Cytoskeletal networks and the regulation of cardiac contractility: microtubules, hypertrophy, and cardiac dysfunction. , 2006, American journal of physiology. Heart and circulatory physiology.
[25] F. Gao,et al. ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction. , 2010, Human gene therapy.
[26] J. Williams,et al. Parathyroid ablation in dystrophic hamsters. Effects on Ca content and histology of heart, diaphragm, and rectus femoris. , 1981, The Journal of clinical investigation.
[27] Hyung-Suk Kim,et al. Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo , 2006, Proceedings of the National Academy of Sciences.
[28] T. Thum,et al. Cardiac fibrosis revisited by microRNA therapeutics. , 2012, Circulation.
[29] T. Borg,et al. Functional arrangement of connective tissue in striated muscle with emphasis on cardiac muscle. , 1982, Scanning electron microscopy.
[30] B. Hinz,et al. Regulation of myofibroblast activities: calcium pulls some strings behind the scene. , 2010, Experimental cell research.
[31] Johan Verjans,et al. Myocardial remodeling after infarction: the role of myofibroblasts , 2010, Nature Reviews Cardiology.
[32] F. Shang,et al. Ubiquitin-proteasome pathway and cellular responses to oxidative stress. , 2011, Free radical biology & medicine.
[33] A. Ooshima,et al. Collagen in dilated cardiomyopathy--scanning electron microscopic and immunohistochemical observations. , 1992, Japanese circulation journal.
[34] Gabriela E Garcia. ANG II receptor antagonists as modulators of macrophages polarization. , 2010, American journal of physiology. Renal physiology.
[35] J. S. Janicki,et al. Myocardial fibrosis: functional significance and regulatory factors. , 1993, Cardiovascular research.
[36] K. Weber,et al. Prevention of liver fibrosis by triple helix-forming oligodeoxyribonucleotides targeted to the promoter region of type I collagen gene. , 2010, Oligonucleotides.
[37] A. Desmoulière,et al. Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity , 2004, Virchows Archiv.
[38] P. ten Dijke,et al. Exploring anti-TGF-β therapies in cancer and fibrosis , 2011, Growth factors.
[39] M. Frey,et al. Consequences of uncontrolled calcium entry and its prevention with calcium antagonists. , 1983, European heart journal.
[40] C. H. Conrad,et al. Transition from compensated hypertrophy to systolic heart failure in the spontaneously hypertensive rat: Structure, function, and transcript analysis. , 2010, Genomics.
[41] Z. Krajcer,et al. Coronary artery disease in hypertrophic cardiomyopathy. , 1985, The American journal of cardiology.
[42] B. Fanburg,et al. The effect of lathyrogen beta-amino proprionitrile (BAPN) on the mechanical properties of experimentally hypertrophied rat cardiac muscle. , 1978, Circulation research.
[43] S. Factor,et al. Skeletal framework of mammalian heart muscle. Arrangement of inter- and pericellular connective tissue structures. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[44] H. Karagueuzian. Targeting cardiac fibrosis: a new frontier in antiarrhythmic therapy? , 2011, American journal of cardiovascular disease.
[45] J. Schaper,et al. Progression From Compensated Hypertrophy to Failure in the Pressure-Overloaded Human Heart: Structural Deterioration and Compensatory Mechanisms , 2003, Circulation.
[46] B. Fanburg,et al. The Effect of the Lathyrogen βP‐Amino Proprionitrile (BAPN) on the Mechanical Properties of Experimentally Hypertrophied Rat Cardiac Muscle , 1978 .
[47] K. Weber,et al. Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisited. , 2011, European heart journal.
[48] A. Fishman,et al. Aerobic limit of the heart perfused at constant pressure. , 1980, The American journal of physiology.
[49] A. Becker,et al. Dilated cardiomyopathy is associated with an increase in the type I/type III collagen ratio: a quantitative assessment. , 1995, Journal of the American College of Cardiology.
[50] Marc K. Halushka,et al. Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome , 2006, Science.
[51] S. Shroff,et al. Collagen Remodeling of the Pressure‐Overloaded, Hypertrophied Nonhuman Primate Myocardium , 1988, Circulation research.
[52] S. Rohr,et al. Abolishing Myofibroblast Arrhythmogeneicity by Pharmacological Ablation of &agr;-Smooth Muscle Actin Containing Stress Fibers , 2011, Circulation research.
[53] Q. Lin,et al. Increased Angiotensin-(1-7)–Forming Activity in Failing Human Heart Ventricles: Evidence for Upregulation of the Angiotensin-Converting Enzyme Homologue ACE2 , 2003, Circulation.
[54] K. Weber,et al. Cells expressing angiotensin II receptors in fibrous tissue of rat heart. , 1996, Cardiovascular research.
[55] J. Finsterer,et al. The Heart in Human Dystrophinopathies , 2003, Cardiology.
[56] M. Aoki,et al. Inhibition of experimental abdominal aortic aneurysm in a rat model by the angiotensin receptor blocker valsartan. , 2008, International journal of molecular medicine.
[57] P. Collier,et al. Diagnostics and therapeutic interventions in myocardial interstitial disease, a previously neglected pathology. , 2012, QJM : monthly journal of the Association of Physicians.
[58] W. Roberts,et al. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. , 1979, The American journal of cardiology.
[59] C A Beltrami,et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. , 1994, Circulation.
[60] K. Weber,et al. Mitochondriocentric Pathway to Cardiomyocyte Necrosis in Aldosteronism: Cardioprotective Responses to Carvedilol and Nebivolol , 2011, Journal of cardiovascular pharmacology.
[61] Arantxa González,et al. Collagen Cross-Linking But Not Collagen Amount Associates With Elevated Filling Pressures in Hypertensive Patients With Stage C Heart Failure: Potential Role of Lysyl Oxidase , 2012, Hypertension.
[62] Kenneth McDonald,et al. Diastolic Heart Failure: Evidence of Increased Myocardial Collagen Turnover Linked to Diastolic Dysfunction , 2007, Circulation.
[63] K. Weber,et al. Triplex-forming oligonucleotides as modulators of gene expression. , 2003, The international journal of biochemistry & cell biology.
[64] X. Zhang,et al. Molecular requirements for induction of CTGF expression by TGF-beta1 in primary osteoblasts. , 2008, Bone.
[65] A. Rodríguez-Sinovas,et al. Calcium-mediated cell death during myocardial reperfusion. , 2012, Cardiovascular research.
[66] F. Oakley,et al. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis , 2005, Apoptosis.
[67] K. Weber,et al. Mitochondria-targeted Cardioprotection in Aldosteronism , 2011, Journal of cardiovascular pharmacology.
[68] W. Steffee,et al. Myocardial Healing and Repair after Experimental Infarction in the Rabbit , 1983, Circulation research.
[69] Heiko Mahrholdt,et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.
[70] Arantxa González,et al. Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure. , 2006, Journal of the American College of Cardiology.
[71] M. Varela,et al. Chronic AT(1) blockade stimulates extracellular collagen type I degradation and reverses myocardial fibrosis in spontaneously hypertensive rats. , 2000, Hypertension.
[72] B. Hinz,et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. , 2012, The American journal of pathology.
[73] H. Lan. Transforming growth factor‐β/Smad signalling in diabetic nephropathy , 2012, Clinical and experimental pharmacology & physiology.
[74] L. Katwa,et al. Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. , 1997, Journal of molecular and cellular cardiology.
[75] J. S. Janicki,et al. Cardioreparative Effects of Lisinopril in Rats With Genetic Hypertension and Left Ventricular Hypertrophy , 1991, Circulation.
[76] Gregory M. Fomovsky,et al. Regional mechanics determine collagen fiber structure in healing myocardial infarcts. , 2012, Journal of molecular and cellular cardiology.
[77] J S Janicki,et al. Fibrosis-induced reduction of endomyocardium in the rat after isoproterenol treatment. , 1989, Circulation research.
[78] B. Lopez,et al. Chronic AT1 Blockade Stimulates Extracellular Collagen Type I Degradation and Reverses Myocardial Fibrosis in Spontaneously Hypertensive Rats , 2000 .
[79] D. Rifkin,et al. Matrix control of transforming growth factor-β function. , 2012, Journal of biochemistry.
[80] P. Anthony. Robbins' Pathologic Basis of Disease , 1990 .
[81] D. Ganten,et al. Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats. , 2010, American journal of hypertension.
[82] A. Fishman,et al. Muscle fiber orientation and connective tissue content in the hypertrophied human heart. , 1982, Laboratory investigation; a journal of technical methods and pathology.
[83] W. Linke,et al. Conformation-regulated mechanosensory control via titin domains in cardiac muscle , 2011, Pflügers Archiv - European Journal of Physiology.
[84] M A Rossi,et al. Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans , 1998, Journal of hypertension.
[85] K. Weber,et al. Tissue angiotensin II in the regulation of inflammatory and fibrogenic components of repair in the rat heart. , 2004, The Journal of laboratory and clinical medicine.
[86] Kenji Suzuki,et al. Cardioprotective Effects of Telmisartan against Heart Failure in Rats Induced By Experimental Autoimmune Myocarditis through the Modulation of Angiotensin-Converting Enzyme-2/Angiotensin 1-7/Mas Receptor Axis , 2011, International journal of biological sciences.
[87] P. Vardas,et al. Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover. , 2008, Journal of the American College of Cardiology.
[88] H. Abboud,et al. NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts. , 2010, Journal of the American Society of Nephrology : JASN.
[89] C. Brilla,et al. Lisinopril-Mediated Regression of Myocardial Fibrosis in Patients With Hypertensive Heart Disease , 2000, Circulation.
[90] L. Leinwand,et al. Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner. , 2011, Cancer research.
[91] K. Weber,et al. Pouch tissue and angiotensin peptide generation. , 1998, Journal of molecular and cellular cardiology.
[92] Arnold E. Postlethwaite,et al. Infarct scar as living tissue , 2002, Basic Research in Cardiology.
[93] J. Herreros,et al. Is the Heart a Suction Pump , 2011 .
[94] J. Ross,et al. Fiber Orientation in the Canine Left Ventricle during Diastole and Systole , 1969, Circulation research.
[95] Masahiko Hoshijima,et al. Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures. , 2006, American journal of physiology. Heart and circulatory physiology.
[96] F. Gao,et al. Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy. , 2012, Journal of the American College of Cardiology.
[97] M. Schlepper,et al. Myocardial structure and function in patients with aortic valve disease and their relation to postoperative results. , 1978, The American journal of cardiology.
[98] W. Roberts,et al. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. , 1986, Journal of the American College of Cardiology.
[99] O O Blumenfeld,et al. Structure and function of connective tissue in cardiac muscle: collagen types I and III in endomysial struts and pericellular fibers. , 1988, Scanning microscopy.
[100] Y. Beyazit,et al. Review: Pathobiological aspects of the local bone marrow renin-angiotensin system: a review , 2010, Journal of the renin-angiotensin-aldosterone system : JRAAS.
[101] D. Harrison,et al. Vascular Inflammatory Cells in Hypertension , 2012, Front. Physio..
[102] E. Sonnenblick,et al. Coiled Perimysial Fibers of Papillary Muscle in Rat Heart: Morphology, Distribution, and Changes in Configuration , 1988, Circulation research.
[103] C. Kramer,et al. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. , 2012, JACC. Cardiovascular imaging.
[104] J. Schaper,et al. The role of apoptosis in dilated cardiomyopathy , 1999, Herz.
[105] B. Swynghedauw. Molecular Cardiology for the Cardiologists , 1995 .
[106] K. Weber,et al. Valvular interstitial cells express angiotensinogen and cathepsin D, and generate angiotensin peptides. , 1996, The international journal of biochemistry & cell biology.
[107] B. Jugdutt. Left ventricular rupture threshold during the healing phase after myocardial infarction in the dog. , 1987, Canadian journal of physiology and pharmacology.
[108] F Verrecchia,et al. [Cellular and molecular mechanisms of fibrosis]. , 2006, Annales de pathologie.
[109] P. Macdonald,et al. Myocardial infarction increases ACE2 expression in rat and humans. , 2005, European heart journal.
[110] P. Simpson,et al. &bgr;-Myosin Heavy Chain Is Induced by Pressure Overload in a Minor Subpopulation of Smaller Mouse Cardiac Myocytes , 2011, Circulation research.
[111] I. Guha,et al. Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic. , 2007, The international journal of biochemistry & cell biology.
[112] James Q. Yin,et al. Therapeutic strategies against TGF‐β signaling pathway in hepatic fibrosis , 2006 .
[113] D. Harrison,et al. Regulation of T-cell function by endogenously produced angiotensin II. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.
[114] T. Ohtsuki,et al. Connective tissue growth factor induction in a pressure-overloaded heart ameliorated by the angiotensin II type 1 receptor blocker olmesartan , 2010, Hypertension Research.
[115] F. Ramires,et al. Angiotensin II, Transforming Growth Factor-β1and Repair in the Infarcted Heart , 1998 .
[116] R. F. Rushmer,et al. The Mechanics of Ventricular Contraction: A Cinefluorographic Study , 1951, Circulation.
[117] A. Burt,et al. Fibrosis and cirrhosis reversibility - molecular mechanisms. , 2008, Clinics in liver disease.
[118] A. Witkowski,et al. Autophagy in transition from hypertrophic cardiomyopathy to heart failure. , 2010, Journal of electron microscopy.
[119] E. Niggli,et al. Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways. , 2008, Cardiovascular research.
[120] M. Yamagishi,et al. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats. , 2007, American journal of hypertension.
[121] J J Padgett,et al. A renewed sense of self. , 1994, Journal of psychosocial nursing and mental health services.
[122] E. Olson,et al. MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca²⁺ overload and cell death. , 2012, The Journal of clinical investigation.
[123] E. Cho,et al. Relation between flow reserve capacity of penetrating intramyocardial coronary arteries and myocardial fibrosis in hypertension: study using transthoracic Doppler echocardiography. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[124] R. Visse,et al. Matrix Metalloproteinases Regulation and Dysregulation in the Failing Heart , 2002 .
[125] M. Daemen,et al. Angiotensin II Receptor Blockade After Myocardial Infarction in Rats: Effects on Hemodynamics, Myocardial DNA Synthesis, and Interstitial Collagen Content , 1992, Journal of cardiovascular pharmacology.
[126] J. Schisler,et al. Seek and destroy: The ubiquitin-proteasome system in cardiac disease , 2009, Current hypertension reports.
[127] J. Skepper,et al. Epac activation, altered calcium homeostasis and ventricular arrhythmogenesis in the murine heart , 2008, Pflügers Archiv - European Journal of Physiology.
[128] K. Weber,et al. Cultured myofibroblasts generate angiotensin peptides de novo. , 1997, Journal of molecular and cellular cardiology.
[129] M. Simionescu,et al. Interstitial Cells of the Heart Valves Possess Characteristics Similar to Smooth Muscle Cells , 1986, Circulation research.
[130] M. Sugimachi,et al. H2 Mediates Cardioprotection Via Involvements of KATP Channels and Permeability Transition Pores of Mitochondria in Dogs , 2012, Cardiovascular Drugs and Therapy.
[131] M. Daemen,et al. The alpha-smooth muscle actin-positive cells in healing human myocardial scars. , 1994, The American journal of pathology.
[132] H. Lan,et al. Angiotensin II Induces Connective Tissue Growth Factor and Collagen I Expression via Transforming Growth Factor–&bgr;–Dependent and –Independent Smad Pathways: The Role of Smad3 , 2009, Hypertension.
[133] A. Gerdes,et al. Change in cardiac myocyte size distribution in aortic-constricted neonatal rats , 1989, Basic Research in Cardiology.
[134] K. Weber,et al. Aldosteronism and Peripheral Blood Mononuclear Cell Activation: A Neuroendocrine-Immune Interface , 2003, Circulation research.
[135] K. Weber,et al. Angiotensin II and aldosterone receptor binding in rat heart and kidney: response to chronic angiotensin II or aldosterone administration. , 1993, The Journal of laboratory and clinical medicine.
[136] M. Eghbali,et al. Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium. , 1990, Circulation research.
[137] J. Risteli,et al. Atrial extracellular matrix remodelling in patients with atrial fibrillation , 2007, Journal of cellular and molecular medicine.
[138] J. S. Janicki,et al. Myocardial collagen remodeling in pressure overload hypertrophy. A case for interstitial heart disease. , 1989, American journal of hypertension.
[139] K. Weber,et al. Fibrous tissue and angiotensin II. , 1997, Journal of molecular and cellular cardiology.
[140] Qingjian Wang,et al. Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease , 2011, Fibrogenesis & tissue repair.
[141] K. Weber. The cicatrix: a case of woven intrigue. , 1996, Cardiovascular research.
[142] C. Ferrario. Myocardial infarction increases ACE2 expression in rat and humans. , 2005, European heart journal.
[143] M. Sheppard,et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance , 2010 .
[144] S. Factor,et al. Pathologic fibrosis and matrix connective tissue in the subaortic myocardium of patients with hypertrophic cardiomyopathy. , 1991, Journal of the American College of Cardiology.
[145] O. Hess,et al. Intracardiac Angiotensin‐Converting Enzyme Inhibition Improves Diastolic Function in Patients With Left Ventricular Hypertrophy due to Aortic Stenosis , 1994, Circulation.
[146] M. Roth. A quantitative assessment , 1987 .
[147] K. Weber,et al. Regulation of collagen degradation in the rat myocardium after infarction. , 1995, Journal of molecular and cellular cardiology.
[148] P. Steendijk,et al. Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction , 2011, Circulation. Heart failure.
[149] S. Rohr. Myofibroblasts in diseased hearts: new players in cardiac arrhythmias? , 2009, Heart rhythm.
[150] S. Aksu,et al. Over-expression of angiotensin-converting enzyme (CD 143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML , 2006, Leukemia & lymphoma.
[151] P. Whittaker. Unravelling the mysteries of collagen and cicatrix after myocardial infarction. , 1995, Cardiovascular research.
[152] E. Sonnenblick,et al. The heart as a suction pump. , 1986, Scientific American.
[153] E. Griffiths. Mitochondria and heart disease. , 2012, Advances in experimental medicine and biology.
[154] K. Weber,et al. Cardiac interstitium in health and disease: the fibrillar collagen network. , 1989, Journal of the American College of Cardiology.
[155] Wan-Li Ma,et al. Transforming growth factor‐β1 suppresses the up‐regulation of matrix metalloproteinase‐2 by lung fibroblasts in response to tumor necrosis factor‐α , 2011, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[156] H. Vliegen,et al. Changes in nonmyocyte tissue composition associated with pressure overload of hypertrophic human hearts. , 1989, Pathology, research and practice.
[157] S. Factor,et al. Alterations of the myocardial skeletal framework in acute myocardial infarction with and without ventricular rupture. A preliminary report. , 1987, The American journal of cardiovascular pathology.
[158] G. Gabbiani,et al. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction , 1971, Experientia.
[159] J. Penninger,et al. Loss of Angiotensin-Converting Enzyme 2 Accelerates Maladaptive Left Ventricular Remodeling in Response to Myocardial Infarction , 2009, Circulation. Heart failure.
[160] E. Schiffrin,et al. Angiotensin Type 2 Receptor Agonist Compound 21 Reduces Vascular Injury and Myocardial Fibrosis in Stroke-Prone Spontaneously Hypertensive Rats , 2012, Hypertension.
[161] M. Daemen,et al. Collagen remodeling after myocardial infarction in the rat heart. , 1995, The American journal of pathology.
[162] S. Keidar,et al. ACE2 of the heart: From angiotensin I to angiotensin (1-7). , 2007, Cardiovascular research.
[163] H. Lan,et al. Angiotensin II Induces Connective Tissue Growth Factor and Collagen I Expression via Transforming Growth Factor–&bgr;–Dependent and –Independent Smad Pathways: The Role of Smad3 , 2009, Hypertension.
[164] N. Niles. Pathologic Basis of Disease , 1974 .
[165] M. Ackerman,et al. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. , 2011, Journal of the American College of Cardiology.
[166] Hiroyuki Tsutsui,et al. Angiotensin II Type 1 Receptor Blocker Attenuates Exacerbated Left Ventricular Remodeling and Failure in Diabetes-Associated Myocardial Infarction , 2006, Journal of cardiovascular pharmacology.
[167] J. Bauersachs. Regulation of Myocardial Fibrosis by MicroRNAs , 2010, Journal of cardiovascular pharmacology.
[168] P. Matzinger. The Danger Model: A Renewed Sense of Self , 2002, Science.
[169] K. Sunagawa,et al. Angiotensin II Type 1 Receptor Blocker Attenuates Myocardial Remodeling and Preserves Diastolic Function in Diabetic Heart , 2007, Hypertension Research.
[170] K. Weber. A Neuroendocrine-Immune Interface , 2003, Herz.